Blockchain healthcare consortium PharmaLedger has announced the first eight use cases for its initiative. Launched in January 2020, the project is due to last three years. It has a budget of over €20 million, which it received largely from the European Union’s Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). PharmaLedger is comprised of 29 members, including 12 global pharmaceutical companies such as GSK and Novartis.
The use cases focus on the three particular domains the project is centered around. These are providing innovation for supply chains, health data, and clinical trials.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
